PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,455,697 | -34.3% | 87,272 | +8.8% | 0.00% | 0.0% |
| Q2 2023 | $2,215,124 | +77.7% | 80,200 | +48.0% | 0.00% | 0.0% |
| Q1 2023 | $1,246,600 | +110.8% | 54,200 | 0.0% | 0.00% | – |
| Q4 2022 | $591,322 | +75.5% | 54,200 | +35.5% | 0.00% | – |
| Q3 2022 | $337,000 | -7.4% | 40,000 | -13.0% | 0.00% | – |
| Q2 2022 | $364,000 | -87.8% | 46,000 | -63.6% | 0.00% | -100.0% |
| Q1 2022 | $2,995,000 | +90.8% | 126,463 | +175.5% | 0.00% | 0.0% |
| Q4 2021 | $1,570,000 | +93.1% | 45,900 | 0.0% | 0.00% | – |
| Q3 2021 | $813,000 | -60.5% | 45,900 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $2,060,000 | +159.8% | 45,900 | +50.0% | 0.00% | – |
| Q1 2021 | $793,000 | +40.6% | 30,600 | +9.3% | 0.00% | – |
| Q4 2020 | $564,000 | +3.1% | 28,000 | 0.0% | 0.00% | – |
| Q3 2020 | $547,000 | +10.7% | 28,000 | 0.0% | 0.00% | – |
| Q2 2020 | $494,000 | +333.3% | 28,000 | +73.9% | 0.00% | – |
| Q1 2020 | $114,000 | +28.1% | 16,100 | +27.8% | 0.00% | – |
| Q4 2019 | $89,000 | -41.1% | 12,600 | 0.0% | 0.00% | – |
| Q3 2019 | $151,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 750,632 | $7,724,000 | 26.59% |
| BVF INC/IL | 2,617,967 | $26,939,000 | 2.37% |
| GREAT POINT PARTNERS LLC | 982,449 | $10,109,000 | 1.58% |
| Alambic Investment Management, L.P. | 65,128 | $670,000 | 0.53% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,243,202 | $23,083,000 | 0.14% |
| ALGERT GLOBAL LLC | 44,477 | $458,000 | 0.10% |
| Monashee Investment Management LLC | 42,945 | $442,000 | 0.09% |
| Tekla Capital Management LLC | 219,042 | $2,254,000 | 0.08% |
| Spark Investment Management LLC | 138,800 | $1,428,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 187,653 | $1,904,000 | 0.04% |